CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-04). The draft was written by AI, the existence of all 2 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 2117 · Search date 2026-08-04 · Methodology v0.6

High-protein diet,
does it really help with Kidney damage in adults without kidney disease?

30-Second Summary
D
Evidence Grade D · 32 · Safety caution
The short feeding trial did not show impaired kidney function but did not answer long-term clinical injury.
People with chronic kidney disease, albuminuria, kidney-stone risk, or medicines affecting kidney function should discuss a high-protein diet with a clinician.
What the
research shows
The grade is D with 32 points. In OmniHeart, 214 entered run-in, 191 were randomized, 164 completed at least two periods, and 156 entered the kidney analysis. Compared with the 15%-protein diet, six weeks of the 25%-protein diet increased cystatin-C eGFR by 3.81 mL/min/1.73 m² (95% CI 2.54 to 5.09). This may be protein-induced hyperfiltration and cannot be interpreted as kidney protection, functional loss, or clinical kidney damage.
What the
ads claim
The roughly four-unit eGFR rise after the protein diet is a real finding. It should not be converted into 'the kidneys were damaged,' nor into proof of long-term safety.
*

Useful facts when choosing a product

  • The protein diet supplied 25% of energy from protein versus 15% in the carbohydrate diet.
  • All meals were provided, body weight was maintained within 2%, and study foods alone were consumed on more than 95% of feeding days.
  • Cystatin-C eGFR increased by 3.81 mL/min/1.73 m² rather than declining during the protein period.
  • Verdict 2077 is D with 28 points for a beef-containing weight-loss diet; it addresses weight loss rather than kidney damage in healthy adults.
Gap Measurement · Verdict 2117 · D 32
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

In OmniHeart, 214 entered run-in and 191 were randomized to one of six diet sequences. A total of 160 completed all three periods, four completed two, and 156 were included in the kidney-marker analysis. Each diet lasted six weeks. Calories were adjusted to keep body weight within 2% of baseline, and participants consumed only study foods on more than 95% of feeding days. The protein diet supplied 25% protein, 48% carbohydrate, and 27% fat, with 48% of protein from plant sources. NHLBI funded the trial, but kidney markers were not registered key outcomes; they were ancillary to the blood-pressure and lipid primary outcomes.

02

Why this is classified as D (32)

Randomized controlled feeding did not show short-term functional decline, but the small six-week ancillary analysis cannot exclude long-term injury, giving D with 32 points.

Counterpoint. High adherence and isocaloric feeding are strengths. The trial did not test lifetime high-protein intake or clinical kidney events.

Rejudgment record. Cross-check applied — No kidney-function decline during controlled feeding, with long-term uncertainty from a small six-week ancillary analysis

Scoring profile behind this grade
EndpointSSurrogate marker - laboratory or imaging measures
ReplicationR1Single confirmatory trial
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeE0Null
PrecisionC0The confidence interval leaves room for benefit

The scoring table and the verdict agree (D).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Six weeks of a high-protein diet reduces kidney functionDCystatin-C eGFR increased rather than declined.
Long-term clinical kidney damage in healthy adultsDThis six-week ancillary analysis did not measure long-term clinical events and did not establish long-term harm.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Ancillary analysis of a randomized three-period crossover controlled-feeding trial156US National Heart, Lung, and Blood InstituteSix-week cystatin-C-based eGFR, not a registered key outcomeProtein versus carbohydrate diet change difference +3.81 mL/min/1.73 m² (95% CI 2.54 to 5.09); possible hyperfiltration precludes a kidney-protection interpretationDirectly controlled short-term surrogate evidence
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-08-04).

Juraschek SP, Appel LJ, Anderson CAM, Miller ER 3rd. Effect of a high-protein diet on kidney function in healthy adults: results from the OmniHeart trial. Am J Kidney Dis. 2013;61(4):547-554. PMID: 23219108. DOI: 10.1053/j.ajkd.2012.10.017.
checked
ClinicalTrials.gov. OmniHeart Trial: Macronutrients and Cardiovascular Risk. NCT00051350.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-04 · Corrections: none

Cite this verdict

High-protein diet x kidney damage in healthy adults Evidence Grade D card
[Chamgap] High-protein diet x kidney damage in healthy adults — Evidence Grade D·32. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/general/high-protein-diet-kidney-damage-healthy-adults/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.